Skip to content
The Policy VaultThe Policy Vault

abatacept — CareFirst (Caremark)

chronic graft versus host disease

Initial criteria

  • Member has had an inadequate response to systemic corticosteroids OR intolerance or contraindication to corticosteroids

Reauthorization criteria

  • Authorization of 12 months may be granted for members showing positive clinical response

Approval duration

12 months